HbA1c - הרצוי והמצוי

“The patients I’ve started talking to really like [eAG],” says Richard Bergenstal, MD, vice president of medicine and science at ADA, executive director of the International Diabetes Center at Park Nicollet in Minneapolis, and cochair of the eAG committee. “They actually say, ‘What should I do to get closer to the average glucose that would put me at the lowest risk? When should I test?’ It’s gotten us back into the patient’s logbook and back into the glucose meters, which sometimes never happens when you’re just talking about A1C.”

You and the Lab, Partners in Care

The eAG can also help you easily determine whether or not the numbers you see on your meter are telling you the whole story. For example, your meter numbers might all be in the 90 to 130 range, but the eAG says 164. So what’s going on? It may be that you’ve only been testing at certain times, failing to capture the highs that occur, undetected, during the day or at night. “What I say to patients is, ‘Let’s change the testing schedule so we can pick up where blood sugars are going too high.’ Then we can adjust the treatment plan appropriately to lower the high values and improve the overall glucose control,” explains David M. Nathan, MD, of the Diabetes Center at Massachusetts General Hospital and Harvard Medical School, and lead author of the ADAG study.

Still, many diabetes experts who support the use of eAG stress the significance of using A1C too. “The major clinical studies were based on A1C,” explains David B. Sacks, MB, ChB, FRCPath, associate professor of pathology at Harvard Medical School and medical director of clinical chemistry at Brigham and Women’s Hospital. “Many clinical studies use A1C as an indicator of effectiveness of therapy. It’s also used